the in-house research and manufacturing division at Glidewell. The proprietary resin was cleared by the U.S. Food and Drug Administration in 2023 for its in vitro bactericidal and fungicidal effects, ...
the in-house research and manufacturing division at Glidewell. The proprietary resin was cleared by the U.S. Food and Drug Administration in 2023 for its in vitro bactericidal and fungicidal effects, ...
EbsArgent targets urinary tract infections, with early indications of efficacy against many species of multidrug-resistant bacteria STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Thioredoxin ...